These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 15630748)

  • 21. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.
    Chan TM; Li FK; Tang CS; Wong RW; Fang GX; Ji YL; Lau CS; Wong AK; Tong MK; Chan KW; Lai KN
    N Engl J Med; 2000 Oct; 343(16):1156-62. PubMed ID: 11036121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mycophenolate mofetil in low doses stabilizes and improves antineutrophil cytoplasmic antibody-associated vasculitis and lupus nephritis.
    Kazderova M; Jancova E; Rysava R; Merta M; Tesar V
    Arch Med Res; 2008 Jan; 39(1):115-9. PubMed ID: 18068004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fetal malformations associated with mycophenolate mofetil for lupus nephritis.
    El Sebaaly Z; Charpentier B; Snanoudj R
    Nephrol Dial Transplant; 2007 Sep; 22(9):2722. PubMed ID: 17478486
    [No Abstract]   [Full Text] [Related]  

  • 24. Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.
    Zhu B; Chen N; Lin Y; Ren H; Zhang W; Wang W; Pan X; Yu H
    Nephrol Dial Transplant; 2007 Jul; 22(7):1933-42. PubMed ID: 17405792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mycophenolate mofetil--a new therapeutic agent for chronic autoimmune diseases].
    Harboe E; Gøransson L; Wildhagen K; Omdal R
    Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1650-2. PubMed ID: 15976831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mycophenolate mofetil in lupus nephritis].
    Alvarez L; Rivera F; Gil CM; Jiménez del Cerro LA; Olivares J
    Nefrologia; 2002; 22(1):24-32. PubMed ID: 11987681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological therapy of lupus nephritis.
    Fine DM
    JAMA; 2005 Jun; 293(24):3053-60. PubMed ID: 15972568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy of lupus nephritis with mycophenolate mofetil].
    Celić D; Ilić T; Durdević-Mirković T; Mitić I; Milić B; Curić S
    Med Pregl; 2007; 60 Suppl 2():124-7. PubMed ID: 18928177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimalarial myopathy: an underdiagnosed complication? Prospective longitudinal study of 119 patients.
    Casado E; Gratacós J; Tolosa C; Martínez JM; Ojanguren I; Ariza A; Real J; Sanjuán A; Larrosa M
    Ann Rheum Dis; 2006 Mar; 65(3):385-90. PubMed ID: 16096334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myotonic and repetitive discharges in hypokalemic myopathy associated with glycyrrhizin-induced hypochloremia.
    Hayashi R; Maruyama T; Maruyama K; Yanagawa S; Tako K; Yanagisawa N
    J Neurol Sci; 1992 Jan; 107(1):74-7. PubMed ID: 1578237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Congenital monomelic muscular hypertrophy of the upper extremity.
    Gilhuis HJ; Zöphel OT; Lammens M; Zwarts MJ
    Neuromuscul Disord; 2009 Oct; 19(10):714-7. PubMed ID: 19751976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early onset neutropenia after mycophenolate mofetil in systemic sclerosis.
    Cuomo G; Abignano G; Valentini G
    Rheumatol Int; 2009 Oct; 29(12):1529-30. PubMed ID: 19247660
    [No Abstract]   [Full Text] [Related]  

  • 33. Medication-associated lesions of the GI tract.
    Seminerio J; McGrath K; Arnold CA; Voltaggio L; Singhi AD
    Gastrointest Endosc; 2014 Jan; 79(1):140-50. PubMed ID: 24119504
    [No Abstract]   [Full Text] [Related]  

  • 34. Ultrastructural pathology in emetine-induced myopathy.
    Halbig L; Gutmann L; Goebel HH; Brick JF; Schochet S
    Acta Neuropathol; 1988; 75(6):577-82. PubMed ID: 3376760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tonic-clonic seizure following combined treatment of mycophenolate mofetil and acyclovir.
    Lee KM; Kim MK; Wee WR; Lee JH
    Graefes Arch Clin Exp Ophthalmol; 2011 Jul; 249(7):1107-8. PubMed ID: 20857135
    [No Abstract]   [Full Text] [Related]  

  • 36. Focal myopathy induced by chronic heroin injection is reversible.
    Weber M; Diener HC; Voit T; Neuen-Jacob E
    Muscle Nerve; 2000 Feb; 23(2):274-7. PubMed ID: 10639623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Isoniazid-induced myopathy].
    Chaouch N; Mejid M; Zarrouk M; Racil H; Rouhou SC; El Euch G; Chabbou A
    Rev Pneumol Clin; 2011 Dec; 67(6):354-8. PubMed ID: 22137279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycophenolate Mofetil-Induced Status Epilepticus.
    Pellerin D; Singh K; Maniatis T; Chalk CH; Green L
    Can J Neurol Sci; 2018 Sep; 45(5):585-587. PubMed ID: 30234475
    [No Abstract]   [Full Text] [Related]  

  • 39. Skeletal muscle weakness resulting from quinidine ingestion.
    Hall CD; Malouf N
    South Med J; 1987 Mar; 80(3):403-4. PubMed ID: 3824038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polyglucosan body myopathy: a new case.
    Tonin P; Tomelleri G; Vio M; Rizzuto N
    Neuromuscul Disord; 1992; 2(5-6):419-22. PubMed ID: 1300190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.